Trials / Unknown
UnknownNCT06022575
Telehealth Integrated Care Model in Patients With Cardiometabolic Disease
Evaluation of the Telehealth Integrated Care Model in Patients With Hyperlipidemia and Other Cardiometabolic Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,302 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 16 Years – 85 Years
- Healthy volunteers
- —
Summary
The objective of this study is to evaluate the telehealth integrated care model for its clinical efficacy, medical resource utilization, health economics measurement, and satisfaction survey indicators in hyperlipidemia patients and other cardiometabolic diseases. The result of the study will provide evidence for the value of integrated model in the treatment of patients with cardiometabolic syndrome.
Detailed description
Efficacy evaluation is critical for understanding the practical application effect of telehealth integrated mode in the therapy of cardiometabolic disease patients. We can comprehend the influence of the combination of online and offline models on patients' clinical curative effect, medication compliance, medical cost, and satisfaction by analyzing the curative effect and finding a scientific basis for clinical practice and policy formation. As a result, the purpose of this study is to assess the curative effect of hyperlipidemia patients with other cardiometabolic disease using a telehealth integrated model, as well as to investigate the potential benefits and risks of this model in the management of cardiometabolic disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Telehealth integrated care | Followed up in online Internet hospital, estimated and adjusted treatment accroding to clinical efficacy, and send individualized health education messages regularly. |
| PROCEDURE | Conventional health care | Followed up face-to-face in cardiacmetabolic clinics, estimated and adjusted treatment accroding to clinical efficacy, and conducted health education. |
Timeline
- Start date
- 2023-06-20
- Primary completion
- 2024-06-20
- Completion
- 2025-07-20
- First posted
- 2023-09-05
- Last updated
- 2023-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06022575. Inclusion in this directory is not an endorsement.